Proteomics International Laboratories Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Proteomics International Laboratories Ltd
Access all reports
Proteomics International Laboratories Ltd is an Australian life sciences company specializing in predictive diagnostics and analytical services based on proteomics, the study of proteins. The company develops diagnostic tests for chronic diseases, with a focus on its flagship product, PromarkerD, a predictive test for diabetic kidney disease. In addition to diagnostics, Proteomics International provides contract research services, including protein analysis, biomarker discovery, and pharmaceutical testing, supporting drug development and medical research. Proteomics International Laboratories Ltd is headquartered in Perth, Australia, and its shares are listed on the ASX.
Key slides for Proteomics International Laboratories Ltd
Investor Presentation
Proteomics International Laboratories Ltd
Investor Presentation
Proteomics International Laboratories Ltd
Latest articles
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
PIQ
Country
🇦🇺 Australia